Analytical Instrumentation In Life Science - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the analytical instrumentation in life science market size is expected to grow from USD 20.45 billion in 2025 to USD 22.01 billion in 2026 and is forecast to reach USD 31.72 billion by 2031 at 7.60% CAGR over 2026-2031.

This report is Segmented by Type of Product (Chromatographs (Gas Chromatographs, and More), Spectrometer, Liquid Analyzer, and Analytical X-Ray Instrumentation and Analytical Microscopes, and More), End User Vertical (Biopharmaceutical and Nutraceutical (Biologics Manufacturers, and More), and Pharmaceutical), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Analytical Instrumentation In Life Science Market Trends and Insights

Surge in demand for analytical instrumentation in pharmaceutical manufacturing

The FDA's 2025 update to 21 CFR 211.110 formalizes expectations for continuous processing, elevating process-analytical-technology (PAT) systems from optional enhancements to essential control tools. Harmonized ICH Q2(R2) and Q14 guidelines allow platform methods to be validated across multiple products, shrinking timelines and creating sustained pull for multi-attribute chromatography and mass-spectrometry solutions. Manufacturers now rely on real-time attribute measurements to release batches in hours rather than days, a shift that materially increases the installed base of high-performance instruments across development and commercial sites.

Expansion of cell and gene therapy pipeline

Regulators now highlight empty-capsid control and post-translational-modification monitoring as critical quality attributes for viral vectors, pushing biopharma firms toward orbitrap-class mass spectrometry and high-resolution chromatography. Samsung Biologics reduced protein variant analysis from 6-8 weeks to 1-2 weeks by integrating LC-MS/MS with multiplexed workflows, demonstrating the productivity gains attached to next-generation platforms. As global gene-therapy trials multiply, demand for sensitive, high-throughput characterization tools cements spectrometers as pivotal growth engines in the analytical instrumentation in life science market.

High initial cost

Capital budgets remain tightly controlled; 64% of laboratories report difficulty approving new instrument purchases, and consumables can consume up to 80% of lifetime costs. Instrument-as-a-service models and shared-facility consortia are emerging to offset cash-flow barriers, while miniaturized handheld spectrometers projected to reach USD 4 billion by 2030 offer tailored, lower-priced alternatives for niche assays.

Other drivers and restraints analyzed in the detailed report include:

1. Regulatory push for in-line PAT in continuous manufacturing
2. Growing public-private funding in omics and biomarker research
3. Shortage of skilled analytical chemists and data scientists

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The spectrometer category contributed USD 7.1 billion to the analytical instrumentation in life science market size in 2025 and is set to grow at an 8.06% CAGR through 2031. Liquid chromatographs preserved a 66.85% slice of chromatography revenue, but ion chromatographs now register 8.1% growth on the back of trace-impurity testing mandates. Orbitrap Astral Zoom debuted in 2025 with 35% faster scan rates, enabling real-time peptide-mapping of complex biologics and cementing high-resolution MS as the preferred platform for cell-therapy analytics. Gas-chromatography vendors respond to helium shortages by integrating hydrogen-safety interlocks and nitrogen-switch kits, limiting carrier-gas costs for QC labs. Micro-XRF instruments gain traction for non-destructive elemental mapping in controlled-release tablet coatings, extending their reach beyond traditional materials science. Novel gas analyzers oriented toward bioprocess monitoring now post 8.92% annual growth, reflecting the shift toward continuous biomanufacturing workflows that rely on in-line CO2 and O2 analytics.

Second-generation spectrometers further reduce acquisition costs per data point, widening adoption in mid-tier firms without diluting analytical power. As instrument throughput rises, consumable vendors bundle ultralow-void columns and high-capacity trapping cartridges, creating a holistic ecosystem that enhances vendor lock-in. The analytical instrumentation in life science market therefore benefits from hardware, software, and reagent co-development that optimizes complete workflows rather than isolated instrument performance.

Complete Report Scope:

• By Type of Product
  • Chromatographs
    • Gas Chromatographs (GC)
    • Liquid Chromatographs (HPLC, UHPLC)
    • Ion Chromatographs
  • Spectrometer (Mass, Elemental Analysis and Molecular Analysis)
    • Mass Spectrometry
      • LC-MS
      • GC-MS
      • MALDI-TOF
    • Elemental Analysis
      • ICP-MS
      • ICP-OES
    • Molecular Analysis
      • FT-IR
      • Raman
      • UV-Vis
  • Gas Analyzer
    • Laser-Based Gas Analyzers
    • Electrochemical Gas Analyzers
    • Photoacoustic Gas Analyzers
  • Liquid Analyzer
    • pH/ORP Analyzers
    • Dissolved Oxygen (DO) Analyzers
    • Conductivity and Total Organic Carbon (TOC) Analyzers
  • Analytical X-ray Instrumentation and Analytical Microscopes
    • X-ray Diffraction (XRD)
    • X-ray Fluorescence (XRF)
    • Electron Microscopes (SEM, TEM)
    • Atomic Force Microscopes (AFM)
• By End User Vertical
  • Biopharmaceutical and Nutraceutical
    • Biologics Manufacturers
    • Nutraceutical Producers
  • Pharmaceutical
    • Active Pharmaceutical Ingredient (API) Manufacturers
    • Contract Research and Manufacturing Organizations (CROs/CDMOs)
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Nordics
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Asia-Pacific
    • China
    • Japan
    • India
    • South-East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • Middle East
      • Gulf Cooperation Council Countries
      • Turkey
      • Rest of Middle East
    • Africa
      • South Africa
      • Rest of Africa

Geography Analysis

North America retained 38.95% of 2025 revenue behind its advanced biomanufacturing infrastructure and earliest adoption of continuous-processing guidance. The region's regulatory rigor drives consistent upgrades to high-resolution instruments, and domestic stimulus packages direct USD-scale investments toward on-shore manufacturing resilience.

Asia-Pacific is the fastest-growing territory, operating at a 9.03% CAGR to 2031 as CDMOs scale capacity and governments offer tax incentives for single-use bioreactors and PAT equipment. India's generics sector and Singapore's biologics corridor draw multinational firms that demand standardized QC platforms compatible with global filings, lifting the analytical instrumentation in life science market across the region. China's CRO industry exceeded CNY 64.77 billion in 2023 and continues to import premium LC-MS and UHPLC systems to service complex molecule pipelines.

Europe holds steady growth as PIC/S alignment simplifies multinational instrument validation. Waters' USD 45 million Longbridge plant triples local orbitrap component capacity, underscoring sustained European demand for precision manufacturing inputs. South America is an emerging buyer base; Shimadzu's Mexico subsidiary seeks 150% sales growth by 2028, signalling regional appetite for tier-one instruments. Middle East and Africa remain early-stage but attract pilot-scale investments tied to vaccine self-sufficiency programs, foreshadowing incremental instrument shipments aligned to GMP facility buildouts.

1. Thermo Fisher Scientific Inc.
2. Agilent Technologies Inc.
3. Waters Corporation
4. Shimadzu Corporation
5. Bruker Corporation
6. Danaher Corporation (SCIEX and Pall)
7. PerkinElmer Inc.
8. Mettler Toledo International Inc.
9. Sartorius AG
10. Merck KGaA (MilliporeSigma)
11. Bio-Rad Laboratories Inc.
12. Malvern Panalytical Ltd.
13. Metrohm AG
14. JASCO Corporation
15. JEOL Ltd.
16. LECO Corporation
17. Anton Paar GmbH
18. HORIBA Ltd.
19. Tecan Group Ltd.
20. Hitachi High-Tech Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support